Cargando…
Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic had a great impact on healthcare system and patients. This study aimed to evaluate the effect of the COVID-19 pandemic on the perceptions of patients with inflammatory bowel disease (IBD). METHODS: This prospective multicenter study was co...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Formosan Medical Association, Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040350/ https://www.ncbi.nlm.nih.gov/pubmed/37019722 http://dx.doi.org/10.1016/j.jfma.2023.03.017 |
_version_ | 1784912461537738752 |
---|---|
author | Peng, Yen-Ling Chang, Chung-Hsin Wei, Shu-Chen Huang, Tien-Yu Tai, Wei-Chen Hsu, Wen-Hung Wu, Deng-Chyang Yen, Hsu-Heng Tai, Chi-Ming Chang, Chen-Wang Lin, Wei-Chen Wang, Horng-Yuan Lin, Chun-Chi Kuo, Chia-Jung Chiu, Cheng-Tang Lin, Ching-Pin Lee, Hsi-Chang Wu, Jia-Feng Chung, Chen-Shuan |
author_facet | Peng, Yen-Ling Chang, Chung-Hsin Wei, Shu-Chen Huang, Tien-Yu Tai, Wei-Chen Hsu, Wen-Hung Wu, Deng-Chyang Yen, Hsu-Heng Tai, Chi-Ming Chang, Chen-Wang Lin, Wei-Chen Wang, Horng-Yuan Lin, Chun-Chi Kuo, Chia-Jung Chiu, Cheng-Tang Lin, Ching-Pin Lee, Hsi-Chang Wu, Jia-Feng Chung, Chen-Shuan |
author_sort | Peng, Yen-Ling |
collection | PubMed |
description | BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic had a great impact on healthcare system and patients. This study aimed to evaluate the effect of the COVID-19 pandemic on the perceptions of patients with inflammatory bowel disease (IBD). METHODS: This prospective multicenter study was conducted between July 2021 and December 2021. Patients with IBD answered a structured questionnaire, and their degree of anxiety was assessed using a visual analogue scale (VAS) before and after reading educational materials. RESULTS: A total of 225 (47.67%) patients with Crohn's disease, 244 (51.69%) with ulcerative colitis and 3 (0.64%) with indeterminate colitis were enrolled. Common concerns were adverse events from vaccination (20.34%), and higher risks of developing severe COVID-19 (19.28%) and COVID-19 infection (16.31%) than the general population. Medications deemed by the patients to increase the risk of COVID-19 were immunomodulators (16.10%), anti-tumor necrosis factor-α antagonists (9.96%), and corticosteroids (9.32%). Thirty-five (7.42%) patients self-discontinued IBD medication, of whom 12 (34.28%) had worse symptoms. Older age (>50 years) (OR 1.10, 95% CI 1.01–1.19, p = 0.03), IBD-related complications (OR 1.16, 95% CI 1.04–1.28, p = 0.01), education status below senior high school (OR 1.22, 95% CI 1.08–1.37, p = 0.001), and residing in north–central Taiwan (OR 1.21, 95% CI 1.10–1.34, p < 0.001) were associated with more anxiety. None of the enrolled patients contracted COVID-19. The anxiety VAS score (mean ± SD) improved after reading the educational materials (3.84 ± 2.33 vs. 2.81 ± 1.96, p < 0.001). CONCLUSIONS: The medical behavior of IBD patients was influenced by the COVID-19 pandemic, and their anxiety could be mitigated after education. |
format | Online Article Text |
id | pubmed-10040350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Formosan Medical Association, Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-100403502023-03-27 Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study Peng, Yen-Ling Chang, Chung-Hsin Wei, Shu-Chen Huang, Tien-Yu Tai, Wei-Chen Hsu, Wen-Hung Wu, Deng-Chyang Yen, Hsu-Heng Tai, Chi-Ming Chang, Chen-Wang Lin, Wei-Chen Wang, Horng-Yuan Lin, Chun-Chi Kuo, Chia-Jung Chiu, Cheng-Tang Lin, Ching-Pin Lee, Hsi-Chang Wu, Jia-Feng Chung, Chen-Shuan J Formos Med Assoc Original Article BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic had a great impact on healthcare system and patients. This study aimed to evaluate the effect of the COVID-19 pandemic on the perceptions of patients with inflammatory bowel disease (IBD). METHODS: This prospective multicenter study was conducted between July 2021 and December 2021. Patients with IBD answered a structured questionnaire, and their degree of anxiety was assessed using a visual analogue scale (VAS) before and after reading educational materials. RESULTS: A total of 225 (47.67%) patients with Crohn's disease, 244 (51.69%) with ulcerative colitis and 3 (0.64%) with indeterminate colitis were enrolled. Common concerns were adverse events from vaccination (20.34%), and higher risks of developing severe COVID-19 (19.28%) and COVID-19 infection (16.31%) than the general population. Medications deemed by the patients to increase the risk of COVID-19 were immunomodulators (16.10%), anti-tumor necrosis factor-α antagonists (9.96%), and corticosteroids (9.32%). Thirty-five (7.42%) patients self-discontinued IBD medication, of whom 12 (34.28%) had worse symptoms. Older age (>50 years) (OR 1.10, 95% CI 1.01–1.19, p = 0.03), IBD-related complications (OR 1.16, 95% CI 1.04–1.28, p = 0.01), education status below senior high school (OR 1.22, 95% CI 1.08–1.37, p = 0.001), and residing in north–central Taiwan (OR 1.21, 95% CI 1.10–1.34, p < 0.001) were associated with more anxiety. None of the enrolled patients contracted COVID-19. The anxiety VAS score (mean ± SD) improved after reading the educational materials (3.84 ± 2.33 vs. 2.81 ± 1.96, p < 0.001). CONCLUSIONS: The medical behavior of IBD patients was influenced by the COVID-19 pandemic, and their anxiety could be mitigated after education. Formosan Medical Association, Elsevier 2023-03-27 /pmc/articles/PMC10040350/ /pubmed/37019722 http://dx.doi.org/10.1016/j.jfma.2023.03.017 Text en . Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Original Article Peng, Yen-Ling Chang, Chung-Hsin Wei, Shu-Chen Huang, Tien-Yu Tai, Wei-Chen Hsu, Wen-Hung Wu, Deng-Chyang Yen, Hsu-Heng Tai, Chi-Ming Chang, Chen-Wang Lin, Wei-Chen Wang, Horng-Yuan Lin, Chun-Chi Kuo, Chia-Jung Chiu, Cheng-Tang Lin, Ching-Pin Lee, Hsi-Chang Wu, Jia-Feng Chung, Chen-Shuan Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study |
title | Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study |
title_full | Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study |
title_fullStr | Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study |
title_full_unstemmed | Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study |
title_short | Impact of the COVID-19 pandemic on inflammatory bowel disease care in Taiwan: A multicenter study |
title_sort | impact of the covid-19 pandemic on inflammatory bowel disease care in taiwan: a multicenter study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040350/ https://www.ncbi.nlm.nih.gov/pubmed/37019722 http://dx.doi.org/10.1016/j.jfma.2023.03.017 |
work_keys_str_mv | AT pengyenling impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT changchunghsin impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT weishuchen impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT huangtienyu impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT taiweichen impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT hsuwenhung impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT wudengchyang impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT yenhsuheng impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT taichiming impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT changchenwang impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT linweichen impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT wanghorngyuan impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT linchunchi impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT kuochiajung impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT chiuchengtang impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT linchingpin impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT leehsichang impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT wujiafeng impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy AT chungchenshuan impactofthecovid19pandemiconinflammatoryboweldiseasecareintaiwanamulticenterstudy |